Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer
- PMID: 28699539
- DOI: 10.2174/1381612823666170710125332
Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer
Abstract
The 67 kDa high affinity laminin receptor (67LR) is a non-integrin cell surface receptor for laminin, the major component of basement membranes. Interactions between 67LR and laminin play a major role in mediating cell adhesion, migration, proliferation and survival. 67LR derives from homo- or hetero-dimerization of a 37 kDa cytosolic precursor (37LRP), most probably by fatty acid acylation. Interestingly, 37LRP, also called p40 or OFA/iLR (oncofetal antigen/immature laminin receptor), is a multifunctional protein with a dual activity in the cytoplasm and in the nucleus. In the cytoplasm, 37LRP it is associated with the 40S subunit of ribosome, playing a critical role in protein translation and ribosome biogenesis while in the nucleus it is tightly associated with nuclear structures, and bound to components of the cytoskeleton, such as tubulin and actin. 67LR is mainly localized in the cell membrane, concentrated in lipid rafts. Acting as a receptor for laminin is not the only function of 67LR; indeed, it also acts as a receptor for viruses, bacteria and prions. 67LR expression is increased in neoplastic cells and correlates with an enhanced invasive and metastatic potential. The primary function of 67LR in cancer is to promote tumor cell adhesion to basement membranes, the first step in the invasion-metastasis cascade. Thus, 67LR is overexpressed in neoplastic cells as compared to their normal counterparts and its overexpression is considered a molecular marker of metastatic aggressiveness in cancer of many tissues, including breast, lung, ovary, prostate, stomach, thyroid and also in leukemia and lymphoma. Thus, inhibiting 67LR binding to laminin could be a feasible approach to block cancer progression. Here, we review the current understanding of the structure and function of this molecule, highlighting its role in cancer invasion and metastasis and reviewing the various therapeutic options targeting this receptor that could have a promising future application.
Keywords: Laminin receptor; laminin; leukemia; metastasis; monoclonal antibody; small molecule.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
67 kDa laminin receptor: structure, function and role in cancer and infection.Infez Med. 2012;20 Suppl 2:8-12. Infez Med. 2012. PMID: 23042000 Review.
-
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.Oncotarget. 2015 Jul 20;6(20):18116-33. doi: 10.18632/oncotarget.4016. Oncotarget. 2015. PMID: 26062445 Free PMC article.
-
67 kDa laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach?Transl Med UniSa. 2016 Nov 1;15:8-14. eCollection 2016 Nov. Transl Med UniSa. 2016. PMID: 27896222 Free PMC article.
-
Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.Clin Cancer Res. 1999 Jun;5(6):1465-72. Clin Cancer Res. 1999. PMID: 10389934
-
The 67 kDa laminin receptor: structure, function and role in disease.Biosci Rep. 2008 Feb;28(1):33-48. doi: 10.1042/BSR20070004. Biosci Rep. 2008. PMID: 18269348 Review.
Cited by
-
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.Molecules. 2024 Mar 20;29(6):1373. doi: 10.3390/molecules29061373. Molecules. 2024. PMID: 38543009 Free PMC article. Review.
-
Resveratrol and its metabolites elicit neuroprotection via high-affinity binding to the laminin receptor at low nanomolar concentrations.FEBS Lett. 2024 May;598(9):995-1007. doi: 10.1002/1873-3468.14835. Epub 2024 Feb 27. FEBS Lett. 2024. PMID: 38413095
-
Treatment with YIGSR peptide ameliorates mouse tail lymphedema by 67 kDa laminin receptor (67LR)-dependent cell-cell adhesion.Biochem Biophys Rep. 2023 Jul 20;35:101514. doi: 10.1016/j.bbrep.2023.101514. eCollection 2023 Sep. Biochem Biophys Rep. 2023. PMID: 37521371 Free PMC article.
-
Emerging roles of the cellular prion protein (PrPC) and 37/67 kDa laminin receptor (RPSA) interaction in cancer biology.Cell Mol Life Sci. 2023 Jul 15;80(8):207. doi: 10.1007/s00018-023-04844-2. Cell Mol Life Sci. 2023. PMID: 37452879 Free PMC article. Review.
-
Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review.Int J Mol Sci. 2023 Jun 23;24(13):10519. doi: 10.3390/ijms241310519. Int J Mol Sci. 2023. PMID: 37445697 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources